Product Code: GVR-4-68040-935-0
Synthetic DNA Market Summary
The global synthetic DNA market size was valued at USD 4.1 billion in 2025 and is projected to grow from USD 4.8 billion in 2026 to USD 14.2 billion by 2033, at a CAGR of 16.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 39.8% in 2025. Investment in synthetic DNA development, advances in targeted delivery technologies, and growing adoption of programmable cell-engineering approaches for precision medicine.
Global Synthetic DNA Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global synthetic DNA industry based on product & services, technology, application, end use, and region.
- Product & Service Outlook (Revenue, USD Billion, 2021 - 2033)
- Oligonucleotide Synthesis
- Gene Synthesis
- Plasmid DNA
- DNA Libraries
- Other Synthetic DNA Products & Services
- Technology Outlook (Revenue, USD Billion, 2021 - 2033)
- Chemical/Solid-Phase Synthesis
- Enzymatic DNA Synthesis
- Array-/Chip-Based DNA Synthesis
- Others
- Application Outlook (Revenue, USD Billion, 2021 - 2033)
- Research & Development
- Diagnostics
- Therapeutics & Vaccines
- Synthetic Biology (incl. Industrial & Agri-Food Biotech)
- Other Applications
- End Use Outlook (Revenue, USD Billion, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- CROs & CDMOs
- Diagnostic Laboratories & Companies
- Agricultural & Industrial Biotechnology Companies
- Government & Other Research Organizations
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product & Services
- 1.1.1.2. Technology
- 1.1.1.3. Application
- 1.1.1.4. End Use
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Demand for High-Quality Synthetic DNA in Therapeutic Development
- 3.2.1.2. Increasing Adoption of Synthetic DNA in Synthetic Biology and Gene Editing
- 3.2.1.3. Advancements in DNA Synthesis Technologies
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Challenges in Achieving High Accuracy and Purity
- 3.2.2.2. High Production Costs for Long and Complex DNA Sequences
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
Chapter 4. Product & Services Business Analysis
- 4.1. Segment Dashboard
- 4.2. Synthetic DNA Market: Product & Services Movement Analysis
- 4.3. Oligonucleotide Synthesis
- 4.3.1. Oligonucleotide Synthesis Market, 2021 - 2033 (USD Billion)
- 4.4. Gene Synthesis
- 4.4.1. Gene Synthesis Market, 2021 - 2033 (USD Billion)
- 4.5. Plasmid DNA
- 4.5.1. Plasmid DNA Market, 2021 - 2033 (USD Billion)
- 4.6. DNA Libraries
- 4.6.1. DNA Libraries Market, 2021 - 2033 (USD Billion)
- 4.7. Other Synthetic DNA Products & Services
- 4.7.1. Other Synthetic DNA Products & Services Market, 2021 - 2033 (USD Billion)
Chapter 5. Technology Business Analysis
- 5.1. Segment Dashboard
- 5.2. Synthetic DNA Market: Technology Movement Analysis
- 5.3. Chemical/Solid-Phase Synthesis
- 5.3.1. Chemical/Solid-Phase Synthesis Market, 2021 - 2033 (USD Billion)
- 5.4. Enzymatic DNA Synthesis
- 5.4.1. Enzymatic DNA Synthesis Market, 2021 - 2033 (USD Billion)
- 5.5. Array-/Chip-Based DNA Synthesis
- 5.5.1. Array-/Chip-Based DNA Synthesis Market, 2021 - 2033 (USD Billion)
- 5.6. Others
- 5.6.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 6. Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. Synthetic DNA Market: Application Movement Analysis
- 6.3. Research & Development
- 6.3.1. Research & Development Market, 2021 - 2033 (USD Billion)
- 6.4. Diagnostics
- 6.4.1. Diagnostics Market, 2021 - 2033 (USD Billion)
- 6.5. Therapeutics & Vaccines
- 6.5.1. Therapeutics & Vaccines Market, 2021 - 2033 (USD Billion)
- 6.6. Synthetic Biology (incl. Industrial & Agri-Food Biotech)
- 6.6.1. Synthetic Biology (incl. Industrial & Agri-Food Biotech) Market, 2021 - 2033 (USD Billion)
- 6.7. Other Applications
- 6.7.1. Other Applications Market, 2021 - 2033 (USD Billion)
Chapter 7. End Use Business Analysis
- 7.1. Segment Dashboard
- 7.2. Synthetic DNA Market: End Use Movement Analysis
- 7.3. Pharmaceutical & Biotechnology Companies
- 7.3.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Billion)
- 7.4. Academic & Research Institutes
- 7.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Billion)
- 7.5. CROs & CDMOs
- 7.5.1. CROs & CDMOs Market, 2021 - 2033 (USD Billion)
- 7.6. Diagnostic Laboratories & Companies
- 7.6.1. Diagnostic Laboratories & Companies Market, 2021 - 2033 (USD Billion)
- 7.7. Agricultural & Industrial Biotechnology Companies
- 7.7.1. Agricultural & Industrial Biotechnology Companies Market, 2021 - 2033 (USD Billion)
- 7.8. Government & Other Research Organizations
- 7.8.1. Government & Other Research Organizations Market, 2021 - 2033 (USD Billion)
Chapter 8. Regional Business Analysis
- 8.1. Synthetic DNA Market Share By Region, 2025 & 2033
- 8.2. North America
- 8.2.1. North America Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3. Europe
- 8.3.1. Europe Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. UK Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Germany Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Australia Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4.6. Thailand
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Thailand Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.4.7. South Korea
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. South Korea Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.5. Latin America
- 8.5.1. Latin America Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.6. MEA
- 8.6.1. MEA Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE Synthetic DNA Market, 2021 - 2033 (USD Billion)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait Synthetic DNA Market, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Share/ Position Analysis, 2025
- 9.3. Strategy Mapping
- 9.4. Company Profiles/Listing
- 9.4.1. Twist Bioscience
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Integrated DNA Technologies, Inc (acquired by Danaher Corporation)
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. GenScript
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Thermo Fisher Scientific Inc.
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Eurofins Genomics
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. GENEWIZ (Azenta US Inc.)
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. BIONEER CORPORATION
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. Biosearch Technologies (acquired by LGC Limited)
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Elegen Corporation
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Ribbon Bio
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives